Učitavanje...
Dual HER2 blockade: preclinical and clinical data
The estrogen receptor and human epidermal growth factor receptor (HER) signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancers. Not surprisingly, targeting these pathways provides the most effective therapies in appropriately selected pa...
Spremljeno u:
| Izdano u: | Breast Cancer Res |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4429364/ https://ncbi.nlm.nih.gov/pubmed/25928889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0419-5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|